United States
Germany
Japan
United Kingdom
China
IL-6 mouse monoclonal antibody, clone OTI3A3A8
| Applications | ELISA |
| Reactivities | Human |
Assay Kits
IL-6 mouse monoclonal antibody, clone OTI5G7
| Applications | ELISA |
| Reactivities | Human |
IL-6 mouse monoclonal antibody, clone OTI2C11
| Applications | ELISA |
| Reactivities | Human |
IL-6 mouse monoclonal antibody, clone OTI3E5
| Applications | ELISA |
| Reactivities | Human |
IL-6 mouse monoclonal antibody, clone OTI3A3B1
| Applications | ELISA |
| Reactivities | Human |
IL-6 mouse monoclonal antibody, clone OTI3F3
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) IL-6 mouse monoclonal antibody, clone OTI3A4
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) IL-6 mouse monoclonal antibody, clone OTI3B3
| Applications | ELISA |
| Reactivities | Human |
IL-6 mouse monoclonal antibody, clone OTI3A4
| Applications | ELISA |
| Reactivities | Human |
IL-6 mouse monoclonal antibody, clone OTI3B3
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) IL-6 mouse monoclonal antibody, clone OTI3E5
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) IL-6 mouse monoclonal antibody, clone OTI2C11
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) IL-6 mouse monoclonal antibody, clone OTI3A3B1
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) IL-6 mouse monoclonal antibody, clone OTI3F3
| Applications | ELISA |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) IL-6 mouse monoclonal antibody, clone OTI3A3A8
| Applications | ELISA |
| Reactivities | Human |
活动过滤器
优化搜索结果
Category
Reactivities
Applications
Antibody Hosts
Conjugates
Clonalities
Assay Types
Brands
Pathways
- Cytokine-cytokine receptor interaction (24)
- Cytosolic DNA-sensing pathway (24)
- Graft-versus-host disease (24)
- Hematopoietic cell lineage (24)
- Hypertrophic cardiomyopathy (HCM) (24)
- Jak-STAT signaling pathway (24)
- NOD-like receptor signaling pathway (24)
- Pathways in cancer (24)
- Prion diseases (24)
- Toll-like receptor signaling pathway (24)
